Product image of Lamuna 30 (Desogestrel, Ethinylestradiol) supplied by GNH India

Lamuna 30

Active Ingredient:
Desogestrel, Ethinylestradiol
Origin:
EU

Lamuna 30 (Desogestrel, Ethinylestradiol)

Desogestrel/Ethinylestradiol, the active ingredients in Lamuna 30, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by providing reliable hormonal contraception. It is indicated for contraception and may also help regulate menstrual cycles, offering additional benefits for cycle control.

GNH India supplies Lamuna 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to a global network of healthcare providers.

Manufacturer / TM Owner

Hexal Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lamuna 30, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent unintended pregnancy.

  • Prevention of pregnancy: provides reliable contraceptive protection when taken daily as directed.
  • Regulation of menstrual cycles: helps achieve more predictable bleeding patterns and may reduce menstrual discomfort.
  • Management of dysmenorrhea: can lessen menstrual pain associated with primary dysmenorrhea.

How It Works

  • Desogestrel and ethinylestradiol act synergistically to suppress the hypothalamic‑pituitary‑gonadal axis, inhibiting the mid‑cycle surge of luteinising hormone and preventing ovulation. The estrogen component stabilises the endometrial lining, while the progestogen induces cervical mucus changes that are hostile to sperm and alters endometrial development, reducing the likelihood of fertilisation and implantation.

Side Effects

Lamuna 30 may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Nausea
  • Breast tenderness
  • Headache
  • Weight change
  • Mood changes
  • Spotting between periods

Serious or Rare Side Effects

  • Venous thromboembolism
  • Arterial thrombosis
  • Hypertension
  • Severe allergic reaction (anaphylaxis)
  • Liver dysfunction
  • Visual disturbances

Precautions & Warnings

Before prescribing Lamuna 30, clinicians should consider several precautionary measures to ensure safe use.

  • Cardiovascular risk assessment: evaluate history of thromboembolic events, myocardial infarction or stroke.
  • Smoking status: avoid use in women over 35 who smoke due to increased clot risk.
  • Hepatic function: use with caution in patients with liver disease or impaired hepatic metabolism.
  • Blood pressure monitoring: the estrogen component may elevate blood pressure; monitor regularly.
  • Concomitant medication review: assess for drugs that induce hepatic enzymes which may reduce efficacy.
  • Store at ambient temperature: keep tablets in the original packaging, protect from moisture and light.

Avoid Interactions

Lamuna 30 can interact with other medicines, affecting its contraceptive effectiveness or safety profile.

Major Interactions (Avoid)

  • Potent enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): markedly reduce plasma levels of both hormones, risking contraceptive failure.
  • Anticoagulants (e.g., warfarin): combined use may increase bleeding risk and require closer coagulation monitoring.

Moderate Interactions (Monitor Closely)

  • Certain antibiotics (e.g., tetracycline, metronidazole): may slightly lower hormone concentrations.
  • Herbal supplements (e.g., St. John’s wort): can decrease effectiveness through enzyme induction.
  • Antiepileptic drugs (e.g., valproate): may modestly reduce contraceptive reliability.

Frequently Asked Questions

Lamuna 30 is a combined oral contraceptive indicated for the prevention of unintended pregnancy in women of reproductive age. It may also be prescribed to help regulate menstrual cycles and to reduce menstrual pain associated with primary dysmenorrhea.

Desogestrel (a progestogen) and ethinylestradiol (an estrogen) work together to suppress the hypothalamic‑pituitary‑gonadal axis, preventing the luteinising hormone surge that triggers ovulation. They also thicken cervical mucus and alter the endometrium, creating conditions that are unfavorable for sperm penetration and implantation.

The dosing regimen for Lamuna 30 is determined by the prescribing healthcare professional. Typically, the product is taken as one tablet daily at the same time each day, but the exact schedule and duration should follow the prescriber’s instructions.

Lamuna 30 is not intended for use during pregnancy and should be discontinued if pregnancy occurs. While limited data exist for breastfeeding, combined oral contraceptives are generally considered compatible with lactation, though clinicians may weigh benefits against potential risks for the infant.

To order Lamuna 30, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamuna 30 contains desogestrel and ethinylestradiol, a formulation known for a favorable bleeding profile and lower androgenic activity compared with some older progestogens. Its efficacy in preventing pregnancy is comparable to other combined pills, while the side‑effect spectrum may differ slightly based on the specific progestogen used.

Lamuna 30 tablets should be stored at ambient temperature, below 25 °C, in their original blister pack. Keep them away from moisture, direct sunlight, and excessive heat to maintain product stability throughout its shelf life.

Lamuna 30 is taken orally, usually with water, once each day at the same time. The tablet should be swallowed whole and not split, chewed, or crushed. Consistent daily intake is essential for maintaining contraceptive effectiveness.

The most serious risks include venous thromboembolism, arterial thrombosis, hypertension, severe allergic reactions, and liver dysfunction. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should be evaluated carefully before use.

Lamuna 30 is contraindicated in women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or are smokers over 35 years of age. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desogestrel, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT